Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7539685

Concept 2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
3,162,000,000 JPY
31,648,000,000 JPY
28,404,000,000 JPY
31,648,000,000 JPY
JPY
80,000,000 JPY
3,234,000,000 JPY
26,851,000,000 JPY
JPY
86,000,000 JPY
30,172,000,000 JPY
30,172,000,000 JPY
Transactions with other segments
JPY
27,000,000 JPY
JPY
JPY
-27,000,000 JPY
27,000,000 JPY
JPY
JPY
-28,000,000 JPY
28,000,000 JPY
28,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.